Evan R Goldfischer et al.
Neurourology and urodynamics, 34(1), 37-43 (2013-10-18)
To assess the efficacy and safety of oxybutynin transdermal gel 3% (OTG3%), with propylene glycol for enhanced skin permeation, in patients with urinary incontinence (UI). In this phase 3 study, 626 patients ≥18 years old with urgency and/or mixed UI